The Pro78 residue regulates the capacity of the human immunodeficiency virus type 1 Nef protein to inhibit recycling of major histocompatibility complex class I molecules in an SH3-independent manner

Journal of General Virology

Volumn 87, Issue 8, 2006, Pages 2291-2296

  Casartelli, Nicoletta ^a,d   Giolo, Giorgia ^a   Neri, Francesca ^a   Haller, Claudia ^b   Potestà, Marina ^a   Rossi, Paolo ^a,c   Fackler, Oliver T ^b   Doria, Margherita ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; PROLINE; PROTEIN SH3;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; REGULATORY MECHANISM;

AMINO ACID SUBSTITUTION; FLOW CYTOMETRY; GENE PRODUCTS, NEF; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1; HUMANS; JURKAT CELLS; MUTATION; PROLINE; PROTEIN BINDING; SRC HOMOLOGY DOMAINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33746838437     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81775-0     Document Type: Article

References (33)

1. Arold, S. T. & Baur, A. S. (2001). Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem Sci 26, 356-363.
2. Arold, S., Franken, P., Strub, M. P., Hoh, F., Benichou, S., Benarous, R. & Dumas, C. (1997). The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure 5, 1361-1372.
3. Blagoveshchenskaya, A. D., Thomas, L., Feliciangeli, S. F., Hung, C.-H. & Thomas, G. (2002). HIV-1 Nef downregulates MHC-1 by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111, 853-866.
4. Casartelli, N., Di Matteo, G., Argentini, C. & 7 other authors (2003a). Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children. AIDS 17, 1291-1301.
5. Casartelli, N., Di Matteo, G., Potestà, M., Rossi, P. & Doria, M. (2003b). CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 Nef protein in pediatric AIDS progression. J Virol 77, 11536-11545.
6. Chang, A. H., O'Shaughnessy, M. V. & Jirik, F. R. (2001). Hck SH3 domain-dependent abrogation of Nef-induced class 1 MHC down-regulation. Eur J Immunol 31, 2382-2387.
7. Craig, H. M., Pandori, M. W., Riggs, N. L., Richman, D. D. & Guatelli, J. C. (1999). Analysis of the SH3-binding region of HIV-1 Nefi: partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket. Virology 262, 55-63.
8. Deacon, N. J., Tsykin, A., Solomon, A. & 17 other authors (1995). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991.
9. Fackler, O. T. & Baur, A. S. (2002). Live and let die: Nef functions beyond HIV replication. Immunity 16, 493-497.
10. Fackler, O. T., Kienzie, N., Kremmer, E., Boese, A., Schramm, B., Klimkalt, T., Kucherer, C. & Mueller-Lantzsch, N. (1997). Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur J Biochem 247, 843-851.
11. Fackler, O. T., Luo,,W., Geyer, M., Alberts, A. S. & Peterlin, B. M. (1999). Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol Cell 3, 729-739.
12. Federico, M. (2004). Targeting the Nef induced increase of HIV infectivity. Curr Drug Targets Immune Endocr Metabol Disord 4, 321-326.
13. Geyer, M., Fackler, O. T. & Peterlin, B. M. (2001). Structure-function relationships in HIV-1 Nef. EMBO Rep 2, 580-585.
14. Greenberg, M. E., Iafrate, A. J. & Skowronski, J. (1998). The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J 17, 2777-2789.
15. Hanna, Z., Kay, D. G., Rebai, N., Guimond, A., Jothy, S. & Jolicoeur, P. (1998). Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95, 163-175.
16. Hanna, Z., Weng, X., Kay, D. G., Poudrier, J., Lowell, C. & Jolicoeur, P. (2001). The pathogenicity of human immunodeficiency virus (HIV) type I Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J Virol 75, 9378-9392.
17. Iafrate, A. J., Bronson, S. & Skowronski, J. (1997). Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J 16, 673-684.
18. Kasper, M. R. & Collins, K. L. (2003). Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. J Virol 77, 3041-3049.
19. + T cells in vitro and in vivo. J Virol 71, 8456-8466.
20. Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L. & Desrosiers, R. C. (1995). Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332, 228-232.
21. Krautkrämer, E., Giese, S. I., Gasteier, J. E., Muranyi, W. & Fackler, O. T. (2004). Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J Virol 78, 4085-4097.
22. Larsen, J. E. Massol, R. H., Nieland, T. J. F. & Kirchhausen, T. (2004). HIV Nef-mediated major histocompatibility complex class I down-modulation is independent of Arf6 activity. Mol Biol Cell 15, 323-331.
23. Lee, C.-H., Leung, B., Lemmon, M. A., Zheng, J., Cowburn, D., Kuriyan, J. & Saksela, K. (1995). A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J 14, 5006-5015.
24. Lee, C.-H., Saksela, K., Mirza, U. A., Chait, B. T. & Kuriyan, J. (1996). Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85, 931-942.
25. Le Gall, S., Erdtmann, L., Benichou, S., Berlioz-Torrent, C., Liu, L., Benarous, R., Heard, J.-M. & Schwartz, O. (1998). Nef interacts with the μ subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483-495.
26. Liu, X., Schrager, J. A., Lange, G. D. & Marsh, J. W. (2001). HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular Nef concentrations. J Biol Chem 276, 32763-32770.
27. Mangasarian, A., Piguet V., Wang, J.-K., Chen, Y.-L. & Trono, D. (1999). Nef-induced CD4 and major histocompatibility complex class I (MHC-1) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-1 trafficking. J Virol 73, 1964-1973.
28. Manninen, A., Hiipakka, M., Vihinen, M., Lu, W., Mayer, B. J. & Saksela, K. (1998). SH3-domain binding function of HIV-1 Nef is required for association with a PAK-related kinase. Virology 250, 273-282.
29. Peterlin, B. M. & Trono, D. (2003). Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol 3, 97-107.
30. Riggs, N. L., Craig, H. M., Pandori, M. W. & Guatelli, J. C. (1999). The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC. Virology 258, 203-207.
31. Roeth, J. F., Williams, M., Kasper, M. R., Filzen, T. M. & Collins, K. L. (2004). HIV-1 Nef disrupts MHC-1 trafficking by recruiting AP-1 to the MHC-1 cytoplasmic tail. J Cell Biol 167, 903-913.
32. + viruses but not for down-regulation of CD4. EMBO J 14, 484-491.
33. Yamada, T., Kaji, N., Odawara, T., Chiba, J., Iwamoto, A. & Kitamura, Y. (2003). Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen. J Virol 77, 1589-1594.